Skip to content

Immediate Pressor Response to Oral Salt

Diagnostic Accuracy of Using an Immediate Pressor Response to Oral Salt (IPROS) to Identify Salt Sensitivity of Blood Pressure (SSBP): a Time Series Clinical Trial

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06226636
Acronym
IPROS
Enrollment
300
Registered
2024-01-26
Start date
2023-07-07
Completion date
2025-12-31
Last updated
2024-01-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

High Blood Pressure

Brief summary

The goal of this study is to establish a diagnostic accuracy of an immediate pressor response to oral salt (IPROS) to identify salt sensitivity of blood pressure (SSBP)

Detailed description

Participants are given dietary salt and their BP is measured every 10 minutes for 2 hours. IPROS is diagnosed with significant mean arterial pressure increase For SSBP, participants are put on high salt diet for a week and monitored and low salt week. The Mean arterial pressure difference between high salt and low salt is used to diagnose SSBP

Interventions

OTHERsalt

After ≥8 hr overnight fasting, participants will be required to ingest 780 mg of sodium (2 g salt) and BP measured every 10 minutes for 2 hours to determine IPROS. For SSBP, Participants are put on low salt (50 mmol Na/day) followed by seven days of high salt diet (250 mmol Na/day). Participants' mean arterial pressure (MAP) difference between low- and high-salt diet will be used to define salt sensitivity (MAP≥8 mmHg) and salt resistance (MAP≤5 mmHg).

Sponsors

Mulungushi University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Participants will be included if they are males or females, aged 18-65 years.

Exclusion criteria

* Kidney disease, Cardiovascular disease

Design outcomes

Primary

MeasureTime frameDescription
SSBP2 weeksSalt sensitivity status

Secondary

MeasureTime frameDescription
IPROS2 hoursImmediate pressor response

Countries

Zambia

Contacts

Primary ContactSepiso K Masenga, PhD
sepisomasenga@gmail.com+260977674774

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026